West Nile virus is a new challenge for transplant programs worldwide. It is a mosquito-borne disease, which has become increasingly prevalent in North America since it was first recognized in New York in 1999. A review of a case study and the literature shows that the morbidity and mortality associated with West Nile virus infection and transplant recipients are alarmingly high. Treatment options are limited because of transplant programs' limited experience in working with this virus. Transplant programs must develop action plans for education on West Nile virus and its prevention to decrease the risk of infection among their transplant recipients.
ProwseCV. An ABC for West Nile virus. Transfus Med.2003;13:1–7.
3.
SmithburnKCHughesTPBurkeAWPaulJH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med.1940;20:471–492.
4.
NashDMostashariFFineA, for the 1999 West Nile Outbreak Response Working Group. The outbreak of West Nile virus infection in the New York City Area in 1999. N Engl J Med.2001;344:1807–1814.
5.
PetersenLRHughesJM. West Nile virus encephalitis. N Engl J Med.2002;347:1225–1226.
6.
NguyenQMorrowCNovickL. Intrauterine West Nile virus infection—New York, 2002. MMWR.2002;51:1135–1136.
7.
CampbellGLanciottiRSBernardBLuH. Laboratory-acquired West Nile virus infections-United States, 2002. MMWR.2002;51:1133–1135.
8.
PealerLNMarfinAAPetersenLR, for the West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med.2003;349:1236–1245.
9.
IwamotoMJerniganDBGuaschA, for the West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med.2003;348:2196–2203.
10.
MostashariFBunningMLKitsutaniPT. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet.2001;358:261–264.
11.
ChowersMYLangRNassarF. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis.2001;7:675–678.
12.
PetersenLRMarfinAAGublerDJ. West Nile virus. JAMA.2003;290:524–528.
13.
PetersenLRMarfinAA. West Nile virus: A primer for the clinician. Ann Intern Med.2002;137:173–179.
14.
HubalekZHalouzkaJ. West Nile fever-a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis.1999;5:643–650.
15.
KumarDPrasadGVRZaltzmanJLevyGAHumarA. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation.2004;77:399–402.
16.
HamdanAGreenPMendelsonEKramerMRPitlikSWeinbergerM. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis.2002;4:160–162.
17.
HardingerKLMillerBStorchGADesaiNMBrennanDC. West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients. Am J Transplant.2003;3:1312–1315.
18.
SejvarJJHaddadMBTierneyBC. Neurologic manifestations and outcome of West Nile virus infection. JAMA.2003;290:511–515.
19.
DeSalvoDRoy-ChaudhuryPPeddiR. West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death. Transplantation.2004;77:466–469.
20.
ShepherdJCSubramanianAMontgomeryRA. West Nile virus encephalitis in a kidney transplant recipient. Am J Transplant.2004;4:830–833.
21.
RavindraKVFreifeldAGKalilAC. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: Case series and literature review. Clin Infect Dis.2004;38:1257–1260.
22.
DeepaliKDrebotMAWongSJ. A serprevalence study of West Nile viurs infection in solid organ transplant recipients. Am J Transplant.2004;4:1883–1888.
23.
GouldHLFikrigE. West Nile virus: A growing concern?J Clin Invest.2004;113:1102–1107.
24.
JordanIBrieseTFischerNLauYiu-Nam JLipkinWI. Ribaviron inhibits west nile virus replication and cytopathic effect in neural cells. J Infect Dis.2000;182:1214–1217.
25.
McCarthyTAHadlerJLJulianK. West Nile virus serosurvey and assessment of personal prevention efforts in an area with intense epizootic activity: Connecticut, 2000. Ann N Y Acad Sci.2001;951:307–316.
26.
Kraftcheck DJ, Paterson JM for the Hamilton West Nile Virus Survey Collaborators. Ontario's 2003 West Nile Virus public education campaign: Was anybody listening?Can Commun Dis Rep.2003;29:189–194. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/03vol29/dr2922ea.html. Accessed July 27, 2004.
27.
FradinMSDayJF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med.2004;347:13–18.
